Riluzole, an approved drug for amyotrophic lateral sclerosis that inhibits glutamate release and augments the glutamate transporter SLC1A3,87 has been suggested for repositioning to an anti-colitic drug.88 The gene discussed is SLC1A3; the disease is amyotrophic lateral sclerosis.